Sannidhi Sarvadhavabhatla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sannidhi Sarvadhavabhatla has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Sophia Donaire
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA 94110, USA
3 shared publications - Sulggi A. Lee
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA
3 shared publications - Vivian Pae
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA 94110, USA
3 shared publications - Alton Barbehenn
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA
2 shared publications - Caroline H. Sheikhzadeh
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA 94110, USA
2 shared publications Christopher Pilcher
Department of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA 94110, USA
2 shared publications
Latest Publications
- Open Access
Coordinated Cytokine Responses Are Associated With Rapid HIV Reservoir Decay During Acute Treated HIV Infection
Background: The HIV reservoir is established within days of infection and persists despite antiretroviral therapy (ART). Host immune responses associated with early reservoir decay remain poorly defined. Methods: We analyzed > 500 longitudinal blood samples from 67 individuals treated during acute HIV infection. Plasma cytokines and HIV reservoir size (intact and defective DNA) were quantified longitudinally. Cytokine–reservoir relationships were assessed using unsupervised clustering and complementary mixed-effects nonlinear and linear spline models; counterfactual modeling examined how cytokine concentrations at defined timepoints related to subsequent reservoir trajectories. Results: TNF-α, IL-17A, and IL-10 were significantly associated with intact HIV DNA during the first 24 weeks of ART after false-discovery-rate correction. TNF-α showed one of the strongest associations with intact reservoir decay, whereas IL-10 showed the most consistent association across intact and defective HIV DNA. A coordinated cytokine cluster comprising IFN-γ, IL-10, IL-18, and TNF-α was associated with both reservoir measures. Phase-specific and counterfactual analyses further suggested that associations between several cytokines and reservoir dynamics varied with timing during early ART. These relationships persisted after adjustment for ART initiation timing, baseline viremia, initial CD4+ T-cell count, and longitudinal CD4:CD8 ratio. Discussion: Coordinated inflammatory, antiviral, and immunoregulatory cytokine responses are associated with HIV reservoir decay following ART initiation during acute infection, with some relationships varying over time. These findings may inform future stage-specific HIV cure strategies that leverage the timing and balance of antiviral, inflammatory, and immunoregulatory pathways to limit reservoir persistence. Main Summary: In people initiating ART during acute HIV infection, coordinated inflammatory, antiviral, and immunoregulatory cytokine responses were associated with faster HIV reservoir decay, with TNF-α and IL-10 showing particularly strong and consistent associations.
Open AccessCoordinated Cytokine Responses Are Associated With Rapid HIV Reservoir Decay During Acute Treated HIV Infection
Background: The HIV reservoir is established within days of infection and persists despite antiretroviral therapy (ART). Host immune responses associated with early reservoir decay remain poorly defined. Methods: We analyzed > 500 longitudinal blood samples from 67 individuals treated during acute HIV infection. Plasma cytokines and HIV reservoir size (intact and defective DNA) were quantified longitudinally. Cytokine–reservoir relationships were assessed using unsupervised clustering and complementary mixed-effects nonlinear and linear spline models; counterfactual modeling examined how cytokine concentrations at defined timepoints related to subsequent reservoir trajectories. Results: TNF-α, IL-17A, and IL-10 were significantly associated with intact HIV DNA during the first 24 weeks of ART after false-discovery-rate correction. TNF-α showed one of the strongest associations with intact reservoir decay, whereas IL-10 showed the most consistent association across intact and defective HIV DNA. A coordinated cytokine cluster comprising IFN-γ, IL-10, IL-18, and TNF-α was associated with both reservoir measures. Phase-specific and counterfactual analyses further suggested that associations between several cytokines and reservoir dynamics varied with timing during early ART. These relationships persisted after adjustment for ART initiation timing, baseline viremia, initial CD4+ T-cell count, and longitudinal CD4:CD8 ratio. Discussion: Coordinated inflammatory, antiviral, and immunoregulatory cytokine responses are associated with HIV reservoir decay following ART initiation during acute infection, with some relationships varying over time. These findings may inform future stage-specific HIV cure strategies that leverage the timing and balance of antiviral, inflammatory, and immunoregulatory pathways to limit reservoir persistence. Main Summary: In people initiating ART during acute HIV infection, coordinated inflammatory, antiviral, and immunoregulatory cytokine responses were associated with faster HIV reservoir decay, with TNF-α and IL-10 showing particularly strong and consistent associations.
- Open Access
- 18 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease
Despite antiretroviral therapy (ART), HIV persists in latently-infected cells (the HIV reservoir) which decay slowly over time. Here, leveraging >500 longitudinal samples from 67 people living with HIV (PLWH) treated during acute infection, we developed a mathematical model to predict reservoir decay from peripheral CD4 + T cells. Nonlinear generalized additive models demonstrated rapid biphasic decay of intact DNA (week 0-5: t1/2 ~ 2.83 weeks; week 5-24: t1/2 ~ 15.4 weeks) that extended out to 1 year. These estimates were ~5-fold faster than prior decay estimates among chronic treated PLWH. Defective DNA had a similar biphasic pattern, but data were more variable. Predicted intact and defective decay rates were faster for PLWH with earlier timing of ART initiation, higher initial CD4 + T cell count, and lower pre-ART viral load. In this study, we advanced our limited understanding of HIV reservoir decay at the time of ART initiation, informing future curative strategies targeting this critical time.
- 18 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Open AccessRapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease
Despite antiretroviral therapy (ART), HIV persists in latently-infected cells (the HIV reservoir) which decay slowly over time. Here, leveraging >500 longitudinal samples from 67 people living with HIV (PLWH) treated during acute infection, we developed a mathematical model to predict reservoir decay from peripheral CD4 + T cells. Nonlinear generalized additive models demonstrated rapid biphasic decay of intact DNA (week 0-5: t1/2 ~ 2.83 weeks; week 5-24: t1/2 ~ 15.4 weeks) that extended out to 1 year. These estimates were ~5-fold faster than prior decay estimates among chronic treated PLWH. Defective DNA had a similar biphasic pattern, but data were more variable. Predicted intact and defective decay rates were faster for PLWH with earlier timing of ART initiation, higher initial CD4 + T cell count, and lower pre-ART viral load. In this study, we advanced our limited understanding of HIV reservoir decay at the time of ART initiation, informing future curative strategies targeting this critical time.
- 6 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (772) , eadq1789
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19
Preexisting anti–interferon-α (anti–IFN-α) autoantibodies in blood are associated with susceptibility to life-threatening COVID-19. However, it is unclear whether anti–IFN-α autoantibodies in the airways, the initial site of infection, can also determine disease outcomes. In this study, we developed a multiparameter technology, FlowBEAT, to quantify and profile the isotypes of anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and anti–IFN-α antibodies in longitudinal samples collected over 20 months from the airways and blood of 129 donors spanning mild to severe COVID-19. We found that nasal IgA1 anti–IFN-α autoantibodies were induced after infection onset in more than 70% of mild and moderate COVID-19 cases and were associated with robust anti–SARS-CoV-2 immunity, fewer symptoms, and efficient recovery. Nasal anti–IFN-α autoantibodies followed the peak of host IFN-α production and waned with disease recovery, revealing a regulated balance between IFN-α and anti–IFN-α response. In contrast, systemic IgG1 anti–IFN-α autoantibodies appeared later and were detected only in a subset of patients with elevated systemic inflammation and worsening symptoms. These data reveal a protective role for nasal anti–IFN-α in the immunopathology of COVID-19 and suggest that anti–IFN-α autoantibodies may serve a homeostatic function to regulate host IFN-α after viral infection in the respiratory mucosa.
- 6 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (772) , eadq1789
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19
Preexisting anti–interferon-α (anti–IFN-α) autoantibodies in blood are associated with susceptibility to life-threatening COVID-19. However, it is unclear whether anti–IFN-α autoantibodies in the airways, the initial site of infection, can also determine disease outcomes. In this study, we developed a multiparameter technology, FlowBEAT, to quantify and profile the isotypes of anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and anti–IFN-α antibodies in longitudinal samples collected over 20 months from the airways and blood of 129 donors spanning mild to severe COVID-19. We found that nasal IgA1 anti–IFN-α autoantibodies were induced after infection onset in more than 70% of mild and moderate COVID-19 cases and were associated with robust anti–SARS-CoV-2 immunity, fewer symptoms, and efficient recovery. Nasal anti–IFN-α autoantibodies followed the peak of host IFN-α production and waned with disease recovery, revealing a regulated balance between IFN-α and anti–IFN-α response. In contrast, systemic IgG1 anti–IFN-α autoantibodies appeared later and were detected only in a subset of patients with elevated systemic inflammation and worsening symptoms. These data reveal a protective role for nasal anti–IFN-α in the immunopathology of COVID-19 and suggest that anti–IFN-α autoantibodies may serve a homeostatic function to regulate host IFN-α after viral infection in the respiratory mucosa.